Regarding the subtypes, human epidermal growth factor receptor 2 (HER2) was the most predominant [28,32,51,55,57,58], followed by invasive ductal and lobular carcinomas [36,50,54]. Here, ERBB2 is linked to breast lobular carcinoma.